Literature DB >> 27252396

Genome Stability Requires p53.

Christine M Eischen1.   

Abstract

It is now clear that functional p53 is critical to protect the genome from alterations that lead to tumorigenesis. However, with the myriad of cellular stresses and pathways linked to p53 activation, much remains unknown about how p53 maintains genome stability and the proteins involved. The current understanding of the multiple ways p53 contributes to genome stability and how two of its negative regulators, Mdm2 and Mdmx, induce genome instability will be described.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27252396      PMCID: PMC4888814          DOI: 10.1101/cshperspect.a026096

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  133 in total

1.  Genomic instability in Gadd45a-deficient mice.

Authors:  M C Hollander; M S Sheikh; D V Bulavin; K Lundgren; L Augeri-Henmueller; R Shehee; T A Molinaro; K E Kim; E Tolosa; J D Ashwell; M P Rosenberg; Q Zhan; P M Fernández-Salguero; W F Morgan; C X Deng; A J Fornace
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

2.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

3.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

5.  GADD45 induction of a G2/M cell cycle checkpoint.

Authors:  X W Wang; Q Zhan; J D Coursen; M A Khan; H U Kontny; L Yu; M C Hollander; P M O'Connor; A J Fornace; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.

Authors:  C Pantoja; M Serrano
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

7.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

8.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

9.  Tumor spectrum in ARF-deficient mice.

Authors:  T Kamijo; S Bodner; E van de Kamp; D H Randle; C J Sherr
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

10.  Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression.

Authors:  P E Carroll; M Okuda; H F Horn; P Biddinger; P J Stambrook; L L Gleich; Y Q Li; P Tarapore; K Fukasawa
Journal:  Oncogene       Date:  1999-03-18       Impact factor: 9.867

View more
  35 in total

1.  Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.

Authors:  Jun Wang; Diana M Merino; Nicholas Light; Brian L Murphy; Yong-Dong Wang; Xiaohui Guo; Andrew P Hodges; Lianne Q Chau; Kun-Wei Liu; Girish Dhall; Shahab Asgharzadeh; Erin N Kiehna; Ryan J Shirey; Kim D Janda; Michael D Taylor; David Malkin; David W Ellison; Scott R VandenBerg; Charles G Eberhart; Rosalie C Sears; Martine F Roussel; Richard J Gilbertson; Robert J Wechsler-Reya
Journal:  Cancer Res       Date:  2019-03-18       Impact factor: 12.701

2.  Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.

Authors:  Changlong Liu; Carolyn E Banister; Phillip J Buckhaults
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

Review 3.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

4.  Empirical single-cell tracking and cell-fate simulation reveal dual roles of p53 in tumor suppression.

Authors:  Ann Rancourt; Sachiko Sato; Masahiko S Satoh
Journal:  Elife       Date:  2022-09-20       Impact factor: 8.713

Review 5.  Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.

Authors:  Lilian Makgoo; Salerwe Mosebi; Zukile Mbita
Journal:  Front Mol Biosci       Date:  2022-05-10

6.  Mutant p53 suppresses innate immune signaling to promote tumorigenesis.

Authors:  Monisankar Ghosh; Suchandrima Saha; Julie Bettke; Rachana Nagar; Alejandro Parrales; Tomoo Iwakuma; Adrianus W M van der Velden; Luis A Martinez
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

Review 7.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

Review 8.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

9.  Identification of gastric cancer subtypes based on pathway clustering.

Authors:  Lin Li; Xiaosheng Wang
Journal:  NPJ Precis Oncol       Date:  2021-06-02

10.  The adenoviral protein E4orf4: a probing tool to decipher mechanical stress-induced nuclear envelope remodeling in tumor cells.

Authors:  Kévin Jacquet; Marc-Antoine Rodrigue; Darren E Richard; Josée N Lavoie
Journal:  Cell Cycle       Date:  2020-10-25       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.